In addition to our assistance of multinational companies, our attorneys and regulatory advisors have assisted many public companies traded on exchanges in the US, Canada and Australia. We understand the special nature of publicly traded companies, including the additional transparency, regulatory scrutiny, and securities filing obligations of public companies. We regularly work with foreign associates and securities and tax co-counsel to help achieve our clients' goals.
Members of our firm have assisted with the review and preparation of the intellectual property and clinical regulatory provisions in annual and quarterly filings of forms 10-K, 10-Q and 8-K. We have specifically reviewed the intellectual property and clinical regulatory provisions to make sure they are in compliance with laws and regulations.
We have also helped review, prepare and conduct due diligence with respect to intellectual property and clinical regulatory provisions on initial public offering documents including the S-1 registration statement in both initial and follow-on offerings.
Our substantial experience with public companies has also included:
Our network of trusted co-counsel assists our clients with compliance with the Securities Act of 1933 (“Securities Act”), compliance with the registration and reporting requirements of the Securities Exchange Act of 1934 (“Exchange Act”), and state corporate and securities laws compliance, and assisting in the drafting and review of Private Placement Memorandums (PPMs) for start-up companies. Foreign associates assist our clients with compliance with securities, exchange, and other public company obligations in their individual jurisdictions.
Our US co-counsel assist our clients with compliance with corporate and securities laws including:
For information on these and other legal, regulatory, and business matters, please contact us.
Torrey Pines Law Group, PC serves technology innovators with protecting intellectual property, obtaining regulatory approvals and clearances, and making deals and closing technology transactions throughout the U.S., including in major technology hubs such as San Diego, San Francisco, Palo Alto, San Jose, Silicon Valley, Boston, Cambridge, Chicago, Minneapolis, Houston, Dallas, Atlanta, Denver, Seattle, Portland, Boulder, Orlando, the Research Triangle (Raleigh, Durham, and Chapel Hill), the Mid-Atlantic (New Jersey, New York, Philadelphia, Maryland, Virginia, and Washington, DC), Pittsburgh, Cleveland, Ann Arbor, and throughout Southern California in Los Angeles, Orange County, Irvine, Torrey Pines, Sorrento Valley, and La Jolla.
We have experience with international intellectual property, regulatory and transactional matters pending in Beijing, Shanghai, Shenzhen, and Guangzhou China; Tokyo, Japan; Berlin, Munich and Frankfurt Gemany; Tel Aviv Israel; Mumbai, Bengaluru, and New Delhi India; London and Edinburgh United Kingdom; Vancouver, Toronto, Calgary and Montreal Canada; Dublin, Ireland; Cape Town, South Africa; Mexico City and Tijuana Mexico; Brussels, Belgium; Copenhagen, Denmark; Paris, France; Madrid and Barcelona Spain; Moscow, Russia; Santiago, Chile; Montevideo, Uruguay; Buenos Aires, Argentina; Sao Paulo and Rio de Janeiro Brazil; Seoul, South Korea; Taipei, Taiwan; Hong Kong; Hanoi, Vietnam; Bangkok, Thailand; Kuala Lumpur, Malaysia; Milan, Italy; Singapore; Sydney, Melbourne, Perth and Adelaide Australia; Auckland, New Zealand; Oslo, Norway; Stockholm, Sweden; Helsinki, Finland; Kiev, Ukraine; Budapest, Hungary; Vienna, Austria; Prague, Czechia; Geneva and Lausanne Switzerland; Bahrain; Doha, Qatar; Abu Dhabi and Dubai UAE; and Jeddah, Saudi Arabia.
Public Company Attorneys - Publicly Traded Business Counsel - IPO Intellectual Property Due Diligence - SEC submissions advisors - S-1 Due Diligence - International Patent Portfolio Management - International Product Lifecycle Management - Board of Directors advisors - Regulatory Compliance Lawyers